Amplitude's Rally Fueled by Strong Q2 and Backlog Growth, but Valuation Risk Rises

What happened

Amplitude has rebounded sharply, doubling from its year-to-date lows, as investors cheer robust second-quarter results showing 21% year-over-year revenue growth and a 35% surge in backlog. The company's AI Analytics platform is gaining traction among enterprises, with large customer count up 30% year-over-year and enterprise customers now comprising over 68% of annual recurring revenue. These developments reinforce the master report's observation that Amplitude is successfully executing an enterprise-led, multi-product expansion strategy, with AI features enhancing product stickiness. However, the master report also flagged persistent GAAP losses and heavy AI-related spending, which have not yet translated into meaningful operating leverage, and the current rally may be pricing in an overly optimistic scenario. While the backlog growth suggests durable demand, investors should closely monitor whether margin expansion follows, as the stock's rebound has likely pushed valuation above the master report's base-case implied value of $11.50.

Implication

The strong Q2 performance and backlog growth confirm that Amplitude's AI-driven enterprise strategy is resonating, supporting the bull case of sustained high-teens growth. However, the master report's base case assumed mid-teens growth with breakeven margins, and the current 21% growth exceeds that, but the stock's doubling from lows implies the market is now pricing in something closer to the bull case of 18%+ growth and expanding margins. Given that the master report projected a bull-case value of $14, and the stock has likely risen well above that, the risk-reward has deteriorated, and investors who bought at lower prices may consider trimming. Longer term, the key test is whether Amplitude can convert its growing backlog into sustained profitability; without margin expansion, the high growth multiple may compress. Therefore, new investors should wait for a pullback or evidence of improving unit economics before committing capital, while existing holders should reassess position sizing in light of the elevated valuation.

Thesis delta

The thesis shifts from a cautious potential buy at $8.50 to a more neutral stance as the stock's rebound likely exceeds the master report's base-case and even bull-case implied values. While the revenue and backlog acceleration is a clear positive, the lack of margin improvement and heavy AI spend mean the fundamentals have not changed proportionally to the price. Consequently, the investment case now hinges on execution of profitability, and we would not chase the stock at current levels.